Tecnologías sanitarias
Empresas estadounidenses dedicadas a un sector: tecnologías sanitarias
Estas Empresas estadounidenses operan en el mismo sector, tecnologías sanitarias. Cada una de ellas incluye estadísticas clave como el precio de las acciones, el cambio diario y el volumen de negociación para ayudarle a tomar decisiones de trading más informadas. Tanto si está siguiendo a gigantes del sector como Eli Lilly and Company o si busca valores con un gran volumen de negociación como Pfizer Inc., esta lista le ofrece información valiosa para cualquier estrategia de trading. Filtre y compare empresas y manténgase al tanto de las tendencias del mercado fácilmente.
Símbolo | Cap. de mercado | Precio | Cbo % | Vol. | Vol. rel. | P/B | BPA dil. TTM | Crecimiento BPA dil. TTM YoY | Rendimiento del dividendo % TTM | Calificación de los analistas |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1,09 T USD | 1.152,93 USD | +0,04% | 4,55 M | 2,22 | 39,18 | 29,43 USD | +95,14% | 0,58% | Compra |
 JNJJohnson & Johnson | 650,65 B USD | 269,99 USD | −0,09% | 16,43 M | 2,95 | 31,29 | 8,63 USD | −7,72% | 1,96% | Compra |
 ABBVAbbVie, Inc. | 466,45 B USD | 263,96 USD | −0,02% | 8,18 M | 1,95 | 74,63 | 3,54 USD | +68,31% | 2,59% | Compra |
 MRKMerck & Co., Inc. | 362,35 B USD | 146,87 USD | −0,19% | 31,16 M | 3,85 | 117,39 | 1,25 USD | −80,71% | 2,29% | Compra |
 AZNAstraZeneca PLC | 257,57 B USD | 166,08 USD | −0,04% | 3,06 M | 0,92 | 25,14 | 6,61 USD | +17,00% | 0,00% | Fuerte compra |
 NVSNovartis AG Sponsored ADRDR | 255,41 B USD | 140,37 USD | −0,39% | 2,25 M | 0,74 | 21,18 | 6,63 USD | −4,00% | 2,20% | Neutral |
 TMOThermo Fisher Scientific Inc. | 240,87 B USD | 651,45 USD | −1,04% | 4,58 M | 2,05 | 35,04 | 18,59 USD | +7,60% | 0,28% | Compra |
 AMGNAmgen Inc. | 208,49 B USD | 385,65 USD | +1,55% | 8,53 M | 2,85 | 23,96 | 16,10 USD | +31,70% | 2,58% | Neutral |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 191,08 B USD | 43,24 USD | +0,12% | 10,37 M | 1,13 | 10,57 | 4,09 USD | +12,75% | 2,85% | Neutral |
 GILDGilead Sciences, Inc. | 186,13 B USD | 150,11 USD | −0,52% | 16,42 M | 3,04 | — | −2,66 USD | −152,84% | 2,15% | Compra |
 ABTAbbott Laboratories | 177,55 B USD | 102,61 USD | +0,37% | 27,08 M | 3,60 | 33,17 | 3,09 USD | −61,31% | 2,42% | Compra |
 PFEPfizer Inc. | 157,65 B USD | 27,66 USD | +0,07% | 75,59 M | 2,61 | 36,63 | 0,76 USD | −59,83% | 6,22% | Neutral |
 DHRDanaher Corporation | 148,9 B USD | 211,81 USD | −0,32% | 8,84 M | 2,55 | 37,61 | 5,63 USD | +19,62% | 0,68% | Fuerte compra |
 ISRGIntuitive Surgical, Inc. | 138,95 B USD | 393,33 USD | +2,55% | 4,93 M | 1,96 | 45,08 | 8,73 USD | +21,75% | 0,00% | Compra |
 VRTXVertex Pharmaceuticals Incorporated | 128,84 B USD | 508,34 USD | −1,55% | 2,43 M | 2,84 | 29,57 | 17,19 USD | +22,86% | 0,00% | Compra |
 BMYBristol-Myers Squibb Company | 128,81 B USD | 63,06 USD | +0,35% | 36,85 M | 4,65 | 13,89 | 4,54 USD | +83,17% | 3,98% | Compra |
 MDTMedtronic Plc | 117,85 B USD | 92,13 USD | −0,69% | 15,45 M | 1,91 | 22,68 | 4,06 USD | +12,15% | 3,09% | Compra |
 SYKStryker Corporation | 105,53 B USD | 275,12 USD | −1,79% | 4,81 M | 1,33 | 28,51 | 9,65 USD | +27,71% | 1,26% | Compra |
 SNYSanofi SA Sponsored ADRDR | 101,94 B USD | 42,48 USD | −1,53% | 2,24 M | 0,96 | 21,88 | 1,94 USD | −30,91% | 4,15% | Compra |
 GSKGSK plc Sponsored ADRDR | 100,46 B USD | 50,22 USD | −1,65% | 4,71 M | 1,79 | 15,82 | 3,17 USD | +47,95% | 3,56% | Neutral |
 REGNRegeneron Pharmaceuticals, Inc. | 80,8 B USD | 784,85 USD | −0,58% | 2,47 M | 4,56 | 19,40 | 40,46 USD | +1,95% | 0,47% | Compra |
 BSXBoston Scientific Corporation | 62,81 B USD | 43,34 USD | −0,48% | 29,28 M | 1,28 | 17,57 | 2,47 USD | +46,77% | 0,00% | Compra |
 ARGXargenx SE Sponsored ADRDR | 62,57 B USD | 990,32 USD | −0,55% | 244,02 K | 1,14 | 37,74 | 26,24 USD | +33,38% | 0,00% | Fuerte compra |
 MRNAModerna, Inc. | 61,5 B USD | 154,04 USD | −2,55% | 20,24 M | 1,72 | — | −7,98 USD | −6,20% | 0,00% | Neutral |
 TAKTakeda Pharmaceutical Co. Ltd. Sponsored ADRDR | 61,05 B USD | 18,91 USD | −0,73% | 2,96 M | 1,25 | — | −0,34 USD | −214,18% | 3,09% | Compra |
 NTRANatera, Inc. | 53,25 B USD | 369,39 USD | +0,84% | 3,72 M | 3,07 | — | −1,37 USD | +28,02% | 0,00% | Fuerte compra |
 EWEdwards Lifesciences Corporation | 50,87 B USD | 88,26 USD | +0,01% | 4,26 M | 1,31 | 52,37 | 1,69 USD | +15,05% | 0,00% | Compra |
 BDXBecton, Dickinson and Company | 49,29 B USD | 180,94 USD | −0,24% | 6,42 M | 3,87 | 54,58 | 3,32 USD | −40,38% | 2,32% | Compra |
 TEVATeva Pharmaceutical Industries Limited | 45,42 B USD | 38,98 USD | −0,54% | 5,48 M | 1,13 | 55,40 | 0,70 USD | — | 0,00% | Fuerte compra |
 AAgilent Technologies, Inc. | 44,11 B USD | 156,47 USD | +0,08% | 4,85 M | 2,48 | 30,81 | 5,08 USD | +19,11% | 0,65% | Compra |
 IQVIQVIA Holdings Inc | 43,85 B USD | 266,42 USD | −1,12% | 5,6 M | 3,85 | 33,05 | 8,06 USD | +16,77% | 0,00% | Compra |
 MDLNMedline, Inc. Class A | 41,6 B USD | 31,64 USD | −1,49% | 19,95 M | 2,96 | 37,10 | 0,85 USD | −46,21% | 0,00% | Compra |
 WATWaters Corporation | 41,42 B USD | 421,63 USD | −1,88% | 1,04 M | 1,73 | 105,28 | 4,00 USD | −63,90% | 0,00% | Compra |
 RVMDRevolution Medicines, Inc. | 40,93 B USD | 190,95 USD | −3,04% | 5,94 M | 3,90 | — | −8,81 USD | −95,67% | 0,00% | Fuerte compra |
 IDXXIDEXX Laboratories, Inc. | 40,31 B USD | 511,65 USD | +1,02% | 1,12 M | 2,30 | 35,96 | 14,23 USD | +18,43% | 0,00% | Compra |
 HLNHaleon PLC Sponsored ADRDR | 40,01 B USD | 9,28 USD | −0,85% | 45,17 M | 2,57 | 19,08 | 0,49 USD | +12,39% | 2,02% | Compra |
 ONCBeOne Medicines Ltd. Sponsored ADRDR | 40,01 B USD | 350,84 USD | −0,74% | 438,38 K | 1,14 | 61,65 | 5,69 USD | — | 0,00% | Fuerte compra |
 ILMNIllumina, Inc. | 36,18 B USD | 239,62 USD | −2,27% | 32,59 M | 14,19 | 44,66 | 5,37 USD | −32,04% | 0,00% | Compra |
 DXCMDexCom, Inc. | 33,72 B USD | 89,35 USD | +1,61% | 14,58 M | 3,89 | 35,27 | 2,53 USD | +77,36% | 0,00% | Fuerte compra |
 RPRXRoyalty Pharma Plc Class A | 33,59 B USD | 58,41 USD | −0,88% | 7,1 M | 2,03 | 31,09 | 1,88 USD | −18,22% | 1,58% | Compra |
 ALCAlcon AG | 32,5 B USD | 65,04 USD | −0,21% | 3,46 M | 2,08 | 50,71 | 1,28 USD | −45,93% | 0,52% | Compra |
 RMDResMed Inc. | 32,46 B USD | 224,99 USD | −1,50% | 3,86 M | 3,19 | 21,56 | 10,44 USD | +9,76% | 1,09% | Compra |
 ALNYAlnylam Pharmaceuticals, Inc | 32,06 B USD | 239,56 USD | −2,42% | 2,76 M | 1,91 | 40,45 | 5,92 USD | — | 0,00% | Compra |
 BIIBBiogen Inc. | 31,84 B USD | 215,50 USD | −1,62% | 2,64 M | 3,68 | 38,16 | 5,65 USD | −45,98% | 0,00% | Compra |
 ZTSZoetis, Inc. Class A | 29,5 B USD | 71,40 USD | −2,22% | 9,88 M | 2,17 | 11,75 | 6,08 USD | +4,59% | 2,93% | Compra |
 GEHCGE Healthcare Technologies Inc. | 28,97 B USD | 64,13 USD | −0,49% | 7,63 M | 2,25 | 14,74 | 4,35 USD | −10,91% | 0,22% | Compra |
 ROIVRoivant Sciences Ltd. | 28,73 B USD | 39,77 USD | −0,53% | 32,2 M | 3,58 | — | −0,44 USD | +37,24% | 0,00% | Fuerte compra |
 MTDMettler-Toledo International Inc. | 27,9 B USD | 1.392,32 USD | −1,28% | 544,54 K | 2,78 | 31,34 | 44,43 USD | +12,54% | 0,00% | Neutral |
 INSMInsmed Incorporated | 26,21 B USD | 120,00 USD | −3,21% | 3,45 M | 1,69 | — | −4,11 USD | +28,02% | 0,00% | Fuerte compra |
 WSTWest Pharmaceutical Services, Inc. | 25,5 B USD | 362,31 USD | −1,17% | 1,46 M | 2,62 | 46,32 | 7,82 USD | +17,18% | 0,24% | Fuerte compra |
 INCYIncyte Corporation | 25,4 B USD | 125,31 USD | −1,81% | 3,7 M | 2,79 | 15,97 | 7,85 USD | +78,38% | 0,00% | Compra |
 BNTXBioNTech SE Sponsored ADRDR | 24,13 B USD | 96,06 USD | −2,64% | 1,2 M | 1,40 | — | −7,85 USD | −390,40% | 0,00% | Compra |
 GHGuardant Health, Inc. | 24,07 B USD | 179,38 USD | −2,03% | 3,08 M | 1,90 | — | −3,50 USD | −4,60% | 0,00% | Fuerte compra |
 UTHRUnited Therapeutics Corporation | 21,22 B USD | 494,63 USD | −0,53% | 1,5 M | 2,05 | 17,69 | 27,96 USD | +9,16% | 0,00% | Fuerte compra |
 GMABGenmab A/S Sponsored ADRDR | 20,68 B USD | 34,74 USD | +0,59% | 2,71 M | 1,50 | 27,51 | 1,26 USD | −36,98% | 0,00% | Fuerte compra |
 STESTERIS plc | 19,99 B USD | 205,04 USD | −1,44% | 1,54 M | 2,39 | 25,06 | 8,18 USD | +24,05% | 1,23% | Compra |
 VTRSViatris, Inc. | 19,47 B USD | 16,95 USD | −1,05% | 15,65 M | 2,08 | — | −0,36 USD | +87,72% | 2,83% | Compra |
 ZBHZimmer Biomet Holdings, Inc. | 18,19 B USD | 95,36 USD | +1,18% | 3,95 M | 1,90 | 23,21 | 4,11 USD | +0,06% | 1,01% | Neutral |
 RVTYRevvity, Inc. | 16,01 B USD | 143,45 USD | −2,24% | 3,32 M | 1,61 | 68,13 | 2,11 USD | −10,66% | 0,20% | Neutral |
 JAZZJazz Pharmaceuticals Public Limited Company | 15,63 B USD | 240,74 USD | −1,27% | 2,21 M | 4,02 | 16,60 | 14,50 USD | — | 0,00% | Fuerte compra |
 NBIXNeurocrine Biosciences, Inc. | 14,86 B USD | 146,23 USD | −3,69% | 2,82 M | 2,91 | 21,42 | 6,83 USD | +101,48% | 0,00% | Fuerte compra |
 ASNDAscendis Pharma A/S | 14,77 B USD | 236,72 USD | −0,97% | 1,56 M | 1,63 | 18,04 | 13,12 USD | — | 0,00% | Fuerte compra |
 EXELExelixis, Inc. | 14,46 B USD | 58,36 USD | −0,22% | 5,24 M | 2,61 | 18,33 | 3,18 USD | +52,70% | 0,00% | Compra |
 SMMTSummit Therapeutics Inc | 14,24 B USD | 17,85 USD | +0,73% | 13,06 M | 1,93 | — | −1,12 USD | −11,10% | 0,00% | Compra |
 BBIOBridgeBio Pharma, Inc. | 13,02 B USD | 66,61 USD | −1,04% | 4,1 M | 1,65 | — | −3,57 USD | +12,83% | 0,00% | Fuerte compra |
 HALOHalozyme Therapeutics, Inc. | 12,76 B USD | 112,45 USD | +2,53% | 10,18 M | 7,14 | 33,60 | 3,35 USD | −23,55% | 0,00% | Compra |
 PENPenumbra, Inc. | 12,51 B USD | 317,60 USD | −0,40% | 994,5 K | 2,94 | 77,99 | 4,07 USD | +7,97% | 0,00% | Neutral |
 BMRNBioMarin Pharmaceutical Inc. | 12,38 B USD | 63,94 USD | −1,75% | 4,46 M | 2,50 | 172,39 | 0,37 USD | −89,01% | 0,00% | Compra |
 MDGLMadrigal Pharmaceuticals, Inc. | 12,28 B USD | 531,52 USD | −0,54% | 330,62 K | 1,59 | — | −12,88 USD | −0,28% | 0,00% | Fuerte compra |
 CORTCorcept Therapeutics Incorporated. | 11,92 B USD | 110,29 USD | −3,98% | 17,23 M | 19,06 | 263,41 | 0,42 USD | −62,74% | 0,00% | Compra |
 BAXBaxter International Inc. | 11,79 B USD | 22,80 USD | −0,96% | 9,97 M | 1,70 | — | −1,93 USD | −626,14% | 0,18% | Neutral |
 SNNSmith & Nephew plc Sponsored ADRDR | 11,48 B USD | 27,56 USD | −0,79% | 1,45 M | 0,82 | 18,79 | 1,47 USD | +30,72% | 2,73% | Neutral |
 TECHBio-Techne Corporation | 11,35 B USD | 72,37 USD | −0,06% | 5,02 M | 1,79 | 62,47 | 1,16 USD | +155,44% | 0,44% | Neutral |
 ELANElanco Animal Health, Inc. | 11,2 B USD | 22,42 USD | −1,41% | 7,95 M | 1,54 | — | −0,40 USD | −146,35% | 0,00% | Fuerte compra |
 TWSTTwist Bioscience Corp. | 10,99 B USD | 166,99 USD | +7,35% | 3,07 M | 1,82 | — | −2,22 USD | −53,17% | 0,00% | Compra |
 AXSMAxsome Therapeutics, Inc. | 10,88 B USD | 207,78 USD | −3,03% | 869,32 K | 1,40 | — | −3,76 USD | +25,87% | 0,00% | Fuerte compra |
 COOCooper Companies, Inc. | 10,51 B USD | 55,29 USD | +2,82% | 8,8 M | 1,41 | 18,87 | 2,93 USD | +44,27% | 0,00% | Compra |
 AVTRAvantor, Inc. | 10,5 B USD | 15,52 USD | −2,14% | 14,83 M | 1,67 | — | −0,85 USD | −184,09% | 0,00% | Neutral |
 ALGNAlign Technology, Inc. | 10,49 B USD | 147,61 USD | −1,40% | 1,5 M | 1,75 | 25,61 | 5,76 USD | −2,76% | 0,00% | Compra |
 RDYDr. Reddy's Laboratories Ltd. Sponsored ADRDR | 10,19 B USD | 12,19 USD | 0,00% | 1,89 M | 0,58 | 27,39 | 0,45 USD | −44,33% | 0,53% | Neutral |
 BIOBio-Rad Laboratories, Inc. Class A | 10,11 B USD | 376,41 USD | −1,57% | 324,35 K | 1,28 | 45,60 | 8,25 USD | −29,66% | 0,00% | Neutral |
 RGENRepligen Corporation | 9,98 B USD | 176,89 USD | −0,73% | 1,36 M | 1,48 | 241,09 | 0,73 USD | — | 0,00% | Fuerte compra |
 TXG10x Genomics Inc Class A | 9,98 B USD | 76,60 USD | −0,48% | 2,89 M | 1,05 | — | −0,59 USD | +16,02% | 0,00% | Compra |
 KRYSKrystal Biotech, Inc. | 9,97 B USD | 336,67 USD | −0,61% | 1 M | 4,09 | 42,19 | 7,98 USD | +62,32% | 0,00% | Fuerte compra |
 GMEDGlobus Medical Inc Class A | 9,95 B USD | 74,08 USD | −0,11% | 2,9 M | 1,86 | 18,94 | 3,91 USD | +50,93% | 0,00% | Compra |
 KYMRKymera Therapeutics, Inc. | 9,79 B USD | 117,75 USD | −0,62% | 1,9 M | 3,01 | — | −3,24 USD | +6,73% | 0,00% | Fuerte compra |
 PODDInsulet Corporation | 9,75 B USD | 140,60 USD | −0,67% | 2,51 M | 1,52 | 27,87 | 5,04 USD | +53,51% | 0,00% | Compra |
 GKOSGlaukos Corp | 9,66 B USD | 163,81 USD | +1,48% | 1,46 M | 1,99 | — | −3,26 USD | −96,75% | 0,00% | Fuerte compra |
 CYTKCytokinetics, Incorporated | 9,56 B USD | 68,78 USD | −1,63% | 4,87 M | 2,87 | — | −7,22 USD | −41,03% | 0,00% | Fuerte compra |
 ARWRArrowhead Pharmaceuticals, Inc. | 9,39 B USD | 66,48 USD | −1,86% | 4,02 M | 1,69 | — | −2,24 USD | −77,56% | 0,00% | Fuerte compra |
 BRKRBruker Corporation | 9,35 B USD | 61,39 USD | −2,63% | 2,82 M | 1,20 | — | −0,70 USD | −234,26% | 0,33% | Compra |
 PTGXProtagonist Therapeutics, Inc. | 9,25 B USD | 143,00 USD | −0,49% | 1,84 M | 3,39 | 137,88 | 1,04 USD | +45,54% | 0,00% | Fuerte compra |
 ABVXAbivax SA Sponsored ADRDR | 9,12 B USD | 105,04 USD | −1,82% | 876,03 K | 0,70 | — | −5,25 USD | −41,66% | 0,00% | Fuerte compra |
 IBRXImmunityBio Inc | 8,99 B USD | 8,48 USD | +0,24% | 18,43 M | 1,95 | — | −0,97 USD | −96,55% | 0,00% | Fuerte compra |
 QGENQIAGEN NV | 8,93 B USD | 43,33 USD | −2,37% | 1,75 M | 1,13 | 22,01 | 1,97 USD | +9,47% | 0,81% | Compra |
 TGTXTG Therapeutics, Inc. | 8,71 B USD | 56,87 USD | +0,71% | 5,17 M | 3,51 | 20,71 | 2,75 USD | +633,70% | 0,00% | Fuerte compra |
 PCVXVaxcyte, Inc. | 8,65 B USD | 58,13 USD | −3,71% | 2,72 M | 2,15 | — | −7,71 USD | −83,87% | 0,00% | Fuerte compra |
 CAICaris Life Sciences, Inc. | 8,47 B USD | 29,98 USD | −3,04% | 14,72 M | 3,08 | 80,53 | 0,37 USD | — | 0,00% | Compra |
 PRAXPraxis Precision Medicines, Inc. | 8,35 B USD | 298,95 USD | −3,71% | 829,85 K | 2,69 | — | −12,94 USD | −5,32% | 0,00% | Fuerte compra |
 SYRESpyre Therapeutics, Inc | 7,96 B USD | 90,25 USD | −2,62% | 3,36 M | 3,18 | — | −2,18 USD | +28,51% | 0,00% | Fuerte compra |